BIOLARGO, INC. (BLGO) stock: key figures, P/E, revenue and dividend
Materials · United States · ISIN US09065A1007
BIOLARGO, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 7.77 m USD |
| Gross profit | 3.41 m USD |
| Operating income | -14.86 m USD |
| EBIT | -14.85 m USD |
| Net income | -11.78 m USD |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BIOLARGO, INC.
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
More stocks
- AIxCrypto Holdings, Inc. (AIXC)
- GEE Group Inc. (JOB)
- Chi Special Acquisition Corp. (GDST)
- FRANKLIN WIRELESS CORP (FKWL)
- Blaize Holdings, Inc. (BZAI)
- Townsquare Media, Inc. (TSQ)
- LIVE VENTURES Inc (LIVE)
- Idaho Copper Corp (COPR)
- Health In Tech, Inc. (HIT)
- DESTINATION XL GROUP, INC. (DXLG)
- All In FutureTech Alliance, Inc. (AIFA)
- CREDITRISKMONITOR COM INC (CRMZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.